ESMO Participates in the Launch of the Critical Medicines Alliance (CMA) Forum
ESMO’s membership in the CMA presents an opportunity to secure the inclusion of critical cancer drugs on the ‘Union list of critical medicines’ and prevent their shortages across Europe